BioCentury
ARTICLE | Company News

Cerep, AVE medicinal chemistry deal

November 12, 2001 8:00 AM UTC

Cerep (NM:Cerep) will use its medicinal chemistry technologies to optimize small molecule protein kinase inhibitors for Aventis (AVE) on a fee-for-service basis. ...